Search Within

Alexander Noor Shoushtari

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (10)
  3. Research Letter (4)
Groups
  1. Department of Medicine (36)
  2. GSK Faculty (36)
  3. Hematologic Malignancies, Division of (36)
  4. Human Oncology and Pathogenesis Program (36)
  5. Melanoma Disease Management Team (36)
  6. Melanoma and Immunotherapeutics Service (36)

More Groups

People
  1. Michael Berger (13)
  2. Michael Postow (13)
  3. Ping Chi (13)
  4. Marc Ladanyi (11)
  5. Nikolaus Schultz (11)
  6. David Solit (10)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Clinical Cancer Research (5)
  3. Cancer Research (3)
  4. Nature Genetics (3)
  5. JCO Precision Oncology (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (8)
  3. Nature Publishing Group (7)
  4. American Medical Association (2)
  5. Cell Press (2)
  6. Nature Research (2)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Activating mutations in uveal melanoma convey sensitivity to g-alpha q inhibition
    Meeting Abstract

    Hitchman, T. D.; Ceraudo, E.; Moore, A. R.; Shoushtari, A. N.; Francis, J. H.; Guan, Y.; Chen, J.; Chang, M. T.; Taylor, B. S.; Sakmar, T. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer
    Journal Article

    Hanrahan, A. J.; Sylvester, B. E.; Chang, M. T.; Elzein, A.; Gao, J.; Han, W.; Liu, Y.; Xu, D.; Gao, S. P.; Gorelick, A. N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
    Journal Article

    Yang, C.; Sanchez-Vega, F.; Chang, J. C.; Chatila, W. K.; Shoushtari, A. N.; Ladanyi, M.; Travis, W. D.; Busam, K. J.; Rekhtman, N.
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas
    Meeting Abstract

    Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save